期刊文献+

PLGA包埋硫酸庆大霉素缓释微球的制备及体外释放行为 被引量:15

Preparation and in vitro release behavior of the gentamicin sulfate-encapsulated PLGA microspheres
下载PDF
导出
摘要 以生物可降解乙交酯和丙交酯的无规共聚物(PLGA)为载体,将硫酸庆大霉素分散在PLGA的有机溶液中,采用复乳溶剂挥发法制备了药物缓释微球。研究搅拌速度、PLGA浓度、乳化剂浓度和硫酸庆大霉素溶液体积对微球粒径的影响,观察微球的表面形貌,测定微球粒径、粒径分布和包封率,评价载药微球的体外释放行为。结果表明,采用甲基纤维素为乳化剂制备的微球形态完整,中粒径为(130±30)μm,微球中硫酸庆大霉素的包封率均在36%以上,平均42%,最高达56%。硫酸庆大霉素/PLGA微球具有显著的药物缓释作用,体外释放30d的累积释药率达80%以上。 Poly (D, L-lactide-co-glycolide) (PLGA) biodegradable microspheres with gentamicin sulfate for the local treatment of microbial bone infection were prepared by double emulsion and solvent evaporation method and characterized were studied. The conditions of the microspheres preparation such as the volume of gentamicin sulfate, PLGA concentration in organic solvent, stirring speed, emulsifier concentration were discussed. The surface morphology of the as-prepared microspheres was observed by SEM. The mean diameter and drug content of microspheres were analyzed and the drug release performance in vitro was evaluated. The results indicated that the morphology of the as-prepared PLGA microspheres by using of methyl cellulose as the dispersant was intact with a mean diameter of (1304-30) μm and the average and maximum encapsulation efficiency of gentamicin sulfate was up to 56 %, respectively. The cumulative rate of drug-release over 30 days drug-release time was over 80%, which illustrated satisfactory sustained-release of the gentamicin sulfate encapsulated PLGA microsperes.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2007年第11期682-684,696,共4页 Chinese Journal of Antibiotics
基金 广东省科技计划项目(编号2004A11304001)
关键词 PLGA微球 硫酸庆大霉素 复乳溶剂挥发法 体外释放 PLGA microsphere method In vitro release Gentamicin sulfate Double emulsion and solvent evaporation
  • 相关文献

参考文献11

  • 1Deacon J M, Pagliaro A J, Zelicof S B, et al. Current concept review Prophylactic use of antibiotics for procedures after total hip replacement [J]. J Bone Joint Surg Am, 1996,78(11) : 1755-1770.
  • 2Baro M, Sanchez E, Delgado A, et al. In vitro-in vivo characterization of gentamicin bone implants [J]. J Control Release,2002,83(3):353-364.
  • 3Virto M R, Elorza B, Torrado S, et al. Improvement of gentamicin poly (D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures[J]. Biomaterials,2007,28(5):877-885.
  • 4Li H Y, Chang J. Preparation Characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres [J]. J Control Release, 2005,107 (3) : 463-473.
  • 5Chang H-I, Perrie Y, Coombes A G A. Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone [J]. J Control Release,2006, 110(2) :414-421.
  • 6Anderson J M, Shire M S. Biodegradation and biocompatibility of PLA and PLGA microspheres [J]. Advanced Drug Delivery Reviews, 1997,28 (1) : 5 - 24.
  • 7Singh M, Shirley B, Bajwa K, et al. Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles [J]. J Control Release, 2001,70 ( 1 ) : 21 - 28.
  • 8Lu L, Stamatas G N, Mikos A G. Controlled release of transforming growth factor betal from biodegradable polymer microparticles [J]. J Biomed Mater Res,2000,50(3): 440-451.
  • 9Sivakumar M, Panduranga Rao K. Preparation characterization and in vitro release of gentamicin from coralline hydroxyapatite-gelatin composite microspheres [J]. Biomaterials,2002,23(15) :3175-3181.
  • 10Lee W K, Park J Y, Yang E H, et al. Investigation of the factors influencing the release rates of cyclosporine A-loaded micro-and nanoparticles prepared by high-pressure homogenizer [J]. d Control Release, 2002,84 (3) : 115-123.

二级参考文献2

共引文献2

同被引文献274

引证文献15

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部